The enzyme dihydrodipicolinate reductase (DHDPR) is a component of the lysine biosynthetic pathway in bacteria and higher plants. DHDPR catalyzes the NAD(P)H dependent reduction of 2,3-dihydrodipicolinate to the cyclic imine L-2,3,4,5,-tetrahydropicolinic acid. The dapB gene that encodes dihydrodipicolinate reductase has previously been cloned, but the expression of the enzyme is low and the purification is time consuming. Therefore the E. coli dapB gene was cloned into the pET16b vector to improve the protein expression and simplify the purification. The dapB gene sequence was utilized to design forward and reverse oligonucleotide primers that were used to PCR the gene from Escherichia coli genomic DNA. The primers were designed with NdeI or BamHI restriction sites on the 5’and 3’ terminus respectively. The PCR product was sequenced to confirm the identity of dapB. The gene was cloned into the expression vector pET16b through NdeI and BamHI restriction endonuclease sites. The resulting plasmid containing dapB was transformed into the bacterial strain BL21 (DE3). The transformed cells were utilized to grow and express the histidine-tagged reductase and the protein was purified using Ni-NTA affinity chromatography. SDS/PAGE gel analysis has shown that the protein was 95% pure and has approximate subunit molecular weight of 28 kDa. The protein purification is completed in one day and 3 liters of culture produced approximately 40–50 mgs of protein, an improvement on the previous protein expression and multistep purification.
Citation: Trigoso YD, Evans RC, Karsten WE, Chooback L (2016) Cloning, Expression, and Purification of Histidine-Tagged Escherichia coli Dihydrodipicolinate Reductase. PLoS ONE 11(1): e0146525. doi:10.1371/journal.pone.0146525
Editor: Matthew Anthony Perugini, La Trobe University, AUSTRALIA
Received: August 27, 2015; Accepted: December 19, 2015; Published: January 27, 2016
Copyright: © 2016 Trigoso et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This work was supported in part by funds from an Oklahoma State Regent Grant for Higher Education (021606), P20RR016478 grant from the National Center for Research Resources (NCRR) a component of National Institute of Health (NIH), and a grant from University of Central Oklahoma office of Research (011574, www.uco.edu) and Grants to L. C.
Competing interests: The authors have declared that no competing interest exist.
Dihydrodipicolinate reductase (DHDPR) was isolated from E. coli in 1965 by Farkas and Gilvarg , since then the enzyme from several different species has been isolated and characterized [2–9]. E. coli DHDPR gene (dapB) encodes a polypeptide of 273 amino acid residues. The resulting protein has a monomeric molecular weight of 28,758 Daltons. The active enzyme is a homotetramer. Dihydrodipicolinate reductase (DHDPR) catalyzes the NAD(P)H dependent reduction of the carbon-carbon double bond of the unsaturated dihydrodipicolinate to form the cyclic imine L-2,3,4,5,- tetrahydropicolinate (Fig 1). The enzyme uses both NADH and NADPH equally well as substrates. The kinetic mechanism of the enzyme is sequential ordered with NAD(P)H binding first followed by dihydrodipicolinate and product release ordered with tetrahydropicolinate released first followed by NAD(P)+ [10–15].
Previously, the dapB gene from M. tuberculosis was cloned into the plasmid vector pET22b and transformed into an E. coli strain in order to characterize and study the structure of M. tuberculosis DHDPR . However, cloning of the dapB gene from E. coli into a histidine-tagged (His-tag) expression vector had not been done before. In this paper we report the cloning of the E. coli dapB gene into the pET-16b plasmid vector next to the six His-tag sequence and transformed into the E. coli strain BL21 (DE3), that is ideal for protein expression [16, 17].
Materials and Methods
Enzymes for DNA cloning and amplification were purchased from Invitrogen (Grand Island, NY). The plasmid pET16b was from Novagen (Madison, WI). Bacterial strain BL21(DE3) was from Invitrogen and manipulated and maintained using standard techniques. The Ni-NTA affinity matrix was purchased from Qiagen (Valencia, CA), or Thermo scientific (Waltham, MA). Buffers and all other chemicals were purchased from SIGMA (St. Louis, MO). Oligonucleotides for the cloning of the reductase gene were synthesized by Invitrogen Laboratory. IPTG was from Gold Biotechnology (St. Louis, MO).
Cloning of dapB into the pET-16b vector
Proximity of the dapB gene to the His-tag sequence of pET-16b was kept by utilizing the restriction enzymes NdeI and BamHI. The forward (5’-GAGAATACATATGCATGATGCAAACATCCG-3’) and reverse (5’-GTGGCATGGATCCTTACAAATTATTGAGATC-3’) 30-mer primers for the dapB gene were designed accordingly. Chromosomal DNA was obtained from an overnight culture of E. coli strain JM109 and isolating the genomic DNA using an Invitrogen PureLink Genomic DNA mini kit. The dapB gene was obtained by PCR using 1 μg of chromosomal DNA. Thirty cycles of PCR were done using Platinum pfx DNA polymerase. The PCR product was cleaned with the Ultra PCR Clean-Up Kit from Thermo Scientific and subsequently digested by BamHI and NdeI restriction endonuleases. The pET-16b vector was also digested with BamHI/NdeI restriction endonucleases and cleaned using the same kit. The digested plasmid and PCR product were ligated with T4 DNA ligase resulting in the pDHDPR plasmid. The plasmid was transformed into the bacterial strain BL21 (DE3) using standard procedures. The transformed cells were plated on LB plates containing ampicillin (100 μg/ml) and incubated overnight at 37°C. Each plate contained about 50 colonies. The culture plates were stored at 4°C.
Ten colonies were picked from one of the plates and used to inoculate 5 mL of autoclaved LB broth containing 100 μg/ml ampicillin. The cultures were grown overnight at 37°C with shaking at 250 rpm. The pDHDPR plasmids were isolated using a Qiagen DNA Mini-Prep kit. Each plasmid sample was subjected to digestion by BamHI and a double digestion by both BamHI and NdeI. Agarose gel electrophoresis was carried out on the digested products to confirm an 819 bp insert, the expected size of the DHDPR gene. Six out of 10 colonies contained the insert.
Protein Expression and Purification
E. coli cell cultures containing the cloned gene were grown overnight at 37°C with shaking at 250 rpm in 5 mL of LB broth containing ampicillin (LB/Amp). The overnight cultures were centrifuged to obtain the cell pellets. Cells were harvested by centrifugation at 4,500 × g. Cell pellets were re-suspended in Ni-NTA lysis buffer (50 mM K2HPO4, 300 mM NaCl, pH 8.0) and subjected to sonication on ice with a Misonix Ultrasonic Liquid Processors on a 15 second burst cycle (power 10). The cell homogenate was treated with the protease inhibitor phenylmethylsulfonyl fluoride (PMSF), followed by centrifugation to clarify the cell lysate. Supernatants were tested for enzyme activity and the presence of expressed protein was further verified using SDS-PAGE. A stock solution of culture determined to have the highest expression of DHDPR was prepared in 15% glycerol and stored at -80°C. The selected recombinant plasmid was sequenced using the chain termination method at the University of Oklahoma Health Science Center Sequencing Facility.
For protein purification the bacterial stock solution of the recombinant plasmid was cultured overnight at 37°C in 5 mL of LB/Amp broth in a shaker incubator. The culture was divided into equal amounts between three flasks containing 1 L LB/Amp broth and allowed to grow at 37°C to A600 = 0.9. The culture was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and growth was continued overnight at 25°C in a shaker incubator. The overnight culture was centrifuged at 4500 × g for 60 minutes to obtain a cell pellet, which was re-suspended in 30 mL of lysis buffer (pH 8.0). The re-suspended cells were lysed by sonication. The sonicated mixture was treated with PMFS and centrifuged for 20 minutes to clarify the cell lysate. The supernatant was added to a Ni-NTA matrix and mixed gently at 4°C for an hour to allow binding of DHDPR. The mixture was batch-cleaned using lysis buffer to remove unbound protein and added to a chromatography column. After the matrix was packed and cleaned with lysis buffer, protein was eluted using elution buffers ranging between 100 mM to 300 mM imidazole in lysis buffer (pH 8.0). One milliliter fractions were collected in microcentrifuge tubes and placed on ice. A Bio-Rad protein assay was done to confirm the presence and relative abundance of protein. The protein peak with reductase activity was separated and placed into a dialysis bag and dialyzed in 50 mM phosphate buffer (pH 8.0) to remove the imidazole. Dialysis was carried out against two one liter volumes of phosphate buffer at 4°C. SDS/PAGE was used to analyze the purity of DHDPR following the purification process. The reductase activity was determined according to the method of Reddy et al. . The reductase was incubated with substrate and NAD(P)H in 50 mM phosphate buffer pH 7.5 and the decrease in absorbance at 340 nm was monitored using a ThermoScientific Evolution 260 Bio UV-Vis spectrophotometer.
Results and Discussion
DHDPR eluted from the Ni-NTA resin at 200–250 mM imidazole. A sample of the pooled fractions containing DHDPR was analyzed by SDS-PAGE and the results are shown in Fig 2. As shown in the figure, DHDPR (lane 2) migrates to a position in the gel close to the 26 kDa band in the molecular weight markers in lane one and is close to the expected molecular weight of 28 kDa for DHDPR. The protein was estimated to be about 95% pure. Purification of 3 L of culture yielded approximately 40–50 mg of protein.
The gel was stained with Coomassie Blue. Lane 1: EZ-Run protein molecular weight marker (170, 130, 95, 72, 56, 43, 34, 26, 17, 11 kDa). Lane 2: purified and dialyzed DHDPR.
A DNA fragment containing the E. coli dihydrodipicolinate reductase gene was successfully isolated and cloned into the histidine-tagged pET-16b expression vector. The 819 bp open-reading frame encoded the 273 amino acid polypeptide with subunit molecular mass of 28 kD. The recombinant histidine-tagged protein was purified from E. coli in one step using Ni-NTA affinity chromatography. The purification can be completed in one day and represents a significant improvement over the three day purification procedure of the non-histidine-tagged recombinant protein .
The kinetic properties of the isolated protein were equivalent to the previously cloned reductase [13, 15]. The specific activity (μmols min-1/mg) of the recombinant enzyme reported here is 448 and compares favorably to the published value of 398. In addition, the Km for DHDP for the histidine-tagged enzyme is 43 ± 8 μmolar compared to the published value of about 50 μmolar. The histidine-tagged enzyme also uses both NADH and NADPH as substrates similar to what has been reported previously .
In our lab the reaction of dihydrodipicolinate synthase (DHDPS) is followed in a coupled assay using DHDPR. In this assay the product of the DHDPS-catalyzed reaction is converted by dihydrodipicolinate reductase to product with concomitant conversion of NADH to NAD+. Enzyme activity is monitored spectrophotometrically by measuring the decrease of NADH at 340 nm. The coupled enzyme assay requires relatively high concentrations of DHDPR. The new recombinant produces a high amount of protein which will facilitate kinetic studies of DHDPS.
This work was supported in part by funds from an Oklahoma State Regent Grant for Higher Education (021606), P20RR016478 grant from the National Center for Research Resources (NCRR) a component of National Institute of Health (NIH), and a grant from the University of Central Oklahoma office of Research and Grants to L.C.
Conceived and designed the experiments: LC. Performed the experiments: YDT RCE. Analyzed the data: LC WEK. Contributed reagents/materials/analysis tools: LC. Wrote the paper: LC YDT RCE WEK.
- 1. Farkas W, Gilvarg C. The reduction step in diaminopimelic acid biosynthesis. J. Biol. Chem. 1965; 240(12): 4717–22 pmid:4378965
- 2. Kimura K. A new flavin enzyme catalyzing the reduction dihydrodipicolinate in sporulating Bacillus subtilis: I. Purification and properties. J. Biochem. 1975; 77(2): 405–13 pmid:236291
- 3. Kimura K, Goto T. Dihydrodipicolinate reductases from Bacillus cereus and Bacillus megaterium. J. Biochem. 1977; 81(5): 1367–73 pmid:19431
- 4. Cremer J, Treptow C, Eggeling L, Sahm H. Regulation of enzymes of lysine biosynthesis in Corynebacterium glutamicum. J. Gen. Microbiol. 1988; 134(12): 3221–29. pmid:3151991
- 5. Gunji Y, Tsujimoto N, Shimaoka M, Ogawa-Miyata Y, Sugimoto S, Yasueda H. Characterization of the L-lysine biosynthetic pathway in the obligat methylotroph Methylophilus methylotrophus. Biosci. Biotechnol. Biochem. 2004; 68(7): 1449–60 pmid:15277749
- 6. Cirilli M, Zheng R, Scapin G, Blanchard JS. The three-dimensional structures of the Mycobacterium tuberculosis dihydrodipicolinate reductase-NADH-2, 6-PDC and–NADPH-2,6-PDC complexes. Structural and mutagenic analysis of relaxed nucleotide specificity. Biochemistry. 2003; 42(36): 10644–50 pmid:12962488
- 7. Pearce FG, Sprissler C, Gerrard JA (2008). Characterization of dihydrodipicolinate reductase from Thermotoga maritime reveals evolution of substrate binding kinetics. J. Biochem. 2008; 143(5): 617–23. doi: 10.1093/jb/mvn012. pmid:18250105
- 8. Dommaraju SR, Dogovski C, Czabotar PE, Hor L, Smith BJ, Perugini MA. (2011). Catalytic mechanism and cofactor preference of dihydrodipicolinate reductase from methicillin-resistant Staphylococcus aureus. Arch. Biochem. Biophysic. 2011; 512(2): 167–74
- 9. Girish TS, Navratna V, Gopal B. Structure and nucleotide specificity of Staphylococcus aureus dihydrodipicolinate reductase (dapB). FEBS Lett. 2011; 585(16): 2561–67. doi: 10.1016/j.febslet.2011.07.021. pmid:21803042
- 10. Hutton CA, Perugini MA, Gerrard JA. Inhibition of lysine biosynthesis: an emerging antibiotic strategy. Molecular Biosystems. 2007; 3(7): 458–65 pmid:17579770
- 11. Hutton C, Southwood T, Turner J. (2003) Inhibitors of lysine biosynthesis as antibacterial agents. Mini Reviews in Medicinal Chemistry. 2003; 3(2): 115–27. pmid:12570844
- 12. Bouvier J, Richaud C, Richaud F, Patte J, Stragier P. Nucleotide sequence and expression of the Escherichia coli dapB gene. Journal of Biological Chemistry. 1984; 259(23): 14,829–34
- 13. Reddy S, Sacchettini J, Blanchard J. Expression, purification, and characterization of Escherichia coli dihydrodipicolinate reductase. Biochemistry. 1995; 34: 3492–501. pmid:7893644
- 14. Cornish-Bowden A, Fundamentals of enzyme kinetics. Portland Press: London, 1999
- 15. Karsten WE. Dihydrodipicolinate synthase from Escherichia coli: pH dependent changes in the kinetic mechanism and kinetic mechanism of allosteric inhibition by L-lysine. Biochemistry. 1977; 36(7): 1730–39
- 16. Kefala G, Janowski R, Panjikar S, Mueller-Dieckmann C, Weiss M. Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of dapB (Rv2773c) from Mycobacterium tuberculosis. Acta Crystallogr. F Biol. Crystallogr. 2005; 61(7): 718–21
- 17. Marisch K, Bayer K, Cserjan-Puschmann M, Luchner M, Striedner G. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production. Microbial Cell Factories. 2013; 12(1): 1–1